Last Updated on January 25, 2024 by The Health Master
Pharma Conclave
The recent Pharma Conclave in Hyderabad, organized by the Government of Uttar Pradesh in collaboration with the Bulk Drugs Manufacturers’ Association of India (BDMAI) and the Indian Drug Manufacturers Association (IDMA) – Telangana and Andhra Pradesh chapter, marked a significant milestone in showcasing Uttar Pradesh as a promising hub for investments in the pharma, drug, and medical Device sectors.
The event witnessed the active participation of over 100 key industry leaders, distinguished speakers, government officials, scientists, and entrepreneurs.
Dr. G.N. Singh, advisor to Hon’ble Chief Minister of Uttar Pradesh, welcomed the attendees and set the stage for insightful discussions on the opportunities available in Uttar Pradesh.
Participants and Key Figures
The Pharma conclave served as a platform for diverse participants, including the Chief Executive Officer (CEO) of Invest UP, Abhishek Prakash, who highlighted the significance of Uttar Pradesh and its endeavors to create a favorable destination for investments in the pharma sector.
Invest UP’s Perspective
Abhishek Prakash provided insights into the investor-friendly industry landscape in the state, discussing key policy highlights, such as the UP Industrial Policy, FDI Policy, and Pharma Policy.
UPSIDA’s Emphasis on Parks
Mayur Maheshwari, CEO of UP State Industrial Development Authority (UPSIDA), emphasized the potential of the Bulk Drug Park in Lalitpur and Med-Tech Park in the Yamuna Expressway Industrial Development Authority (YEIDA) region.
Industry leaders were informed about the land banks available across Uttar Pradesh for setting up industries.
Vision of a USD 1 Trillion Economy
Awanish Kumar Awasthi, advisor to Hon’ble Chief Minister, UP, shared the state government’s vision of becoming a USD 1 Trillion economy.
The conducive environment that Uttar Pradesh offers for the growth of the pharma sector was highlighted.
Industry Leaders’ Perspectives
Dr. Krishna Ella, CMD Bharat Biotech, spoke about how Uttar Pradesh could emerge as a significant pharma center by focusing on clinical trials, intermediaries, and specialty chemicals.
Dr. Venkat Jasti, Chairman & CEO of Suven Life Sciences Limited, discussed challenges in the pharma industry, emphasizing the importance of infrastructure.
Interest from NATCO Pharma
Rajiv N of NATCO Pharma expressed interest in establishing labs in the Noida region of UP, showcasing the growing interest from industry players.
Role of Industry Experts
The Government of UP delegation recognized the pivotal role of industry experts and the importance of appointing them as brand ambassadors of the pharma sector in southern India to attract the right kind of investments.
Prominent Dignitaries at the Pharma Conclave
Prominent figures like R K Agrawal, National President of Bulk Drug Manufacturers Association, J Rajamouli, Chairman, Telangana State Board of the Indian Drug Manufacturers’ Association, and others attended the Pharma conclave, adding to its significance.
Key Associations and Positions
Key associations and positions represented included R K Agrawal, J Rajamouli, Dr. A Ramkishan, Dr. J.A.S. Giri, Dr P P Lal Krishna, and VB Kamal Hassan Reddy.
Potential of Pharma Industry in UP
Insights from industry leaders and officials highlighted the tremendous potential of the pharma industry in Uttar Pradesh.
Challenges and Importance of Infrastructure
Dr. Venkat Jasti‘s emphasis on challenges and the importance of infrastructure, including common effluent treatment plants, provided a realistic perspective on the industry’s growth.
Recognition of Industry Experts
Acknowledging industry experts as brand ambassadors showcased a collaborative approach towards promoting the pharma sector.
Investment Opportunities
The Pharma conclave concluded with a focus on the diverse investment opportunities that Uttar Pradesh offers in the pharma sector.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
FAQs
- How can I explore investment opportunities in Uttar Pradesh’s pharma sector?
- Visit the official website of Invest UP for detailed information on available opportunities.
- What are the key policies discussed during the conclave?
- The conclave highlighted key policies such as the UP Industrial Policy, FDI Policy, and Pharma Policy.
- Are there specific regions in Uttar Pradesh earmarked for pharma industry development?
- Yes, regions like Lalitpur and the Yamuna Expressway Industrial Development Authority (YEIDA) offer potential for pharma industry development.
- What challenges did industry leaders discuss during the conclave?
- Challenges discussed included infrastructure issues and the importance of common effluent treatment plants.
- How can industry experts contribute as brand ambassadors to the pharma sector in southern India?
- The government recognized the role of industry experts and aims to appoint them as brand ambassadors to attract investments.
USFDA issues EIR to Indoco Remedies for Goa Plant-1
CDSCO: NSWS Portal Expands Services for Pharma and Medical Devices
CDSCO approval granted for Clinical Trials of XBB.1.5 Vaccine
CDSCO approval granted for this breast cancer treatment drug
USFDA inspection: Key Agendas and Expectations
Unveiling the Battle Against Spurious Drug: Telangana
IPC Alert: A Deep Dive into Mefenamic Acid and its reactions
Bangladesh API Park offers for Indian API industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
